MELISSA FOUTZ: Open Payments
NPI 1316683253 · FORISTELL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$602 in 9 payments from 7 companies in 2025. Trend: 2023 $1,942 · 2024 $581 · 2025 $602
Food & beverage: $602
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 2 | $138 |
| TG Therapeutics, Inc. | 1 | $132 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| Biogen, Inc. | 1 | $125 |
| Grifols USA, LLC | 2 | $37 |
| Amgen Inc. | 1 | $25 |
| UCB, Inc. | 1 | $19 |
Products named: BRIUMVI, NUCALA, TYSABRI, Ocrevus, Gamunex-C, TEZSPIRE, Ocrevus Zunovo, Rystiggo.
Industry payments across MO — which companies pay providers there.
